Predictive Factors of Visual Recovery After Paraoptic Tumors Removal
Key facts
- Who runs it
- Fondation Ophtalmologique Adolphe de Rothschild
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 99 people enrolled
- Started
- 18 Dec 2017
- Ended
- 11 Jan 2024
- Type of study
- Observational
- Record updated
- 11 June 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- tuberculum sellae meningioma surgical indication
Who cannot take part
- surgical contra indication MRI contra indication optical disease
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Paraoptic tumors - including mostly sellar meningiomas, pituitary gland adenomas and craniopharyngiomas - classically affect the visual function. Some preoperative factors, determined on retrospective studies, are known to constitute bad prognostic factors, such as duration of symptoms and retinal nerve fiber layer thinning on OCT. We propose to perform a single center prospective study in which detailed preoperative ophthalmological and radiological criteria will be collected before surgery. Intraoperative information will be noted as well. All these data will be statistically examined regarding the postoperative visual recovery at 3, 6 and 12 months
The group in the trial
- Tuberculum sellae meningiomas
Adult patient suffering from tuberculum sellae meningiomas with surgical treatment
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Paraoptic Tumors : Study of the Radiological, Ophthalmological and Intraoperative Predictive Factors of Visual Recovery After Neurosurgical Removal
- Publications
- Visual outcomes after pituitary adenoma surgery: Associated factors and longitudinal progression in a prospective single-centre study.Clinical neurology and neurosurgery, 2026
- Record updated
- 11 June 2025